|GOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists|
E Eden, R Navon, I Steinfeld, D Lipson, Z Yakhini
BMC bioinformatics 10 (1), 1-7, 2009
|Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing|
GM Frampton, A Fichtenholtz, GA Otto, K Wang, SR Downing, J He, ...
Nature biotechnology 31 (11), 1023-1031, 2013
|Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies|
D Lipson, M Capelletti, R Yelensky, G Otto, A Parker, M Jarosz, JA Curran, ...
Nature medicine 18 (3), 382-384, 2012
|Two-state allosteric behavior in a single-domain signaling protein|
BF Volkman, D Lipson, DE Wemmer, D Kern
Science 291 (5512), 2429-2433, 2001
|Discovering motifs in ranked lists of DNA sequences|
E Eden, D Lipson, S Yogev, Z Yakhini
PLoS Comput Biol 3 (3), e39, 2007
|Oncogenic and drug-sensitive NTRK1 rearrangements in lung cancer|
A Vaishnavi, M Capelletti, AT Le, S Kako, M Butaney, D Ercan, S Mahale, ...
Nature medicine 19 (11), 1469-1472, 2013
|Response to Cabozantinib in patients with RET fusion-positive lung adenocarcinomas|
A Drilon, L Wang, A Hasanovic, Y Suehara, D Lipson, P Stephens, J Ross, ...
Cancer discovery 3 (6), 630-635, 2013
|Comparative genomic hybridization using oligonucleotide microarrays and total genomic DNA|
MT Barrett, A Scheffer, A Ben-Dor, N Sampas, D Lipson, R Kincaid, ...
Proceedings of the National Academy of Sciences 101 (51), 17765-17770, 2004
|Activation of MET via diverse exon 14 splicing alterations occurs in multiple tumor types and confers clinical sensitivity to MET inhibitors|
GM Frampton, SM Ali, M Rosenzweig, J Chmielecki, X Lu, TM Bauer, ...
Cancer discovery 5 (8), 850-859, 2015
|Emergence of constitutively active estrogen receptor-α mutations in pretreated advanced estrogen receptor–positive breast cancer|
R Jeselsohn, R Yelensky, G Buchwalter, G Frampton, F Meric-Bernstam, ...
Clinical cancer research 20 (7), 1757-1767, 2014
|Aberrant overexpression of satellite repeats in pancreatic and other epithelial cancers|
DT Ting, D Lipson, S Paul, BW Brannigan, S Akhavanfard, EJ Coffman, ...
Science 331 (6017), 593-596, 2011
|Kinase fusions are frequent in Spitz tumours and spitzoid melanomas|
T Wiesner, J He, R Yelensky, R Esteve-Puig, T Botton, I Yeh, D Lipson, ...
Nature communications 5 (1), 1-9, 2014
|Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity|
H Beltran, R Yelensky, GM Frampton, K Park, SR Downing, ...
European urology 63 (5), 920-926, 2013
|Blood-based tumor mutational burden as a predictor of clinical benefit in non-small-cell lung cancer patients treated with atezolizumab|
DR Gandara, SM Paul, M Kowanetz, E Schleifman, W Zou, Y Li, ...
Nature medicine 24 (9), 1441-1448, 2018
|New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing|
JS Ross, K Wang, L Gay, R Al-Rohil, JV Rand, DM Jones, HJ Lee, ...
The oncologist 19 (3), 235, 2014
|Quantification of the yeast transcriptome by single-molecule sequencing|
D Lipson, T Raz, A Kieu, DR Jones, E Giladi, E Thayer, JF Thompson, ...
Nature biotechnology 27 (7), 652-658, 2009
|Inflammatory myofibroblastic tumors harbor multiple potentially actionable kinase fusions|
CM Lovly, A Gupta, D Lipson, G Otto, T Brennan, CT Chung, ...
Cancer discovery 4 (8), 889-895, 2014
|Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities|
S Lapidus, JF Thompson, D Lipson, P Milos, JW Efcavitch, S Letovsky
US Patent App. 12/727,824, 2010
|Broad, hybrid capture–based next-generation sequencing identifies actionable genomic alterations in lung adenocarcinomas otherwise negative for such alterations by other …|
A Drilon, L Wang, ME Arcila, S Balasubramanian, JR Greenbowe, ...
Clinical cancer research 21 (16), 3631-3639, 2015
|Targeted next-generation sequencing of head and neck squamous cell carcinoma identifies novel genetic alterations in HPV+ and HPV-tumors|
M Lechner, GM Frampton, T Fenton, A Feber, G Palmer, A Jay, N Pillay, ...
Genome medicine 5 (5), 49, 2013